How Old is Too Old? Closure of Patent Foramen Ovale in Older Patients
Percutaneous closure of a patent foramen ovale (PFO) reduces the risk of recurrent cryptogenic stroke specifically in younger patients. The three randomized controlled trials that led to the widespread adoption of PFO closure excluded patients over the age of 60 years. Older patients frequently have...
Guardado en:
Autores principales: | Carlos Vazquez-Sosa, Stacey D Clegg, James C Blankenship |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b323103fa1b54065adbaba5e98ebeea0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Patent Foramen Ovale Closure in 2019
por: Joel P Giblett, et al.
Publicado: (2019) -
Patent Foramen Ovale Closure: State of the Art
por: Joel P Giblett, et al.
Publicado: (2020) -
Percutaneous closure of the patent foramen ovale: A cardiological perspective
por: S.C. Brown
Publicado: (2017) -
Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
por: Ahmet Hakan Ateş, et al.
Publicado: (2021) -
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study
por: Florence Leclercq, et al.
Publicado: (2021)